Kyndryl Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Kyndryl Holdings, Inc. on July 31, 2026, regarding events occurring on July 30, 2026. The report details the outcomes of the Company's Annual Meeting of Stockholders, including the election of directors, executive compensation votes, and the approval of an amended long-term performance plan.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Stockholders approved several key proposals at the Annual Meeting:
- Amended Long-Term Performance Plan: Stockholders approved the Amended and Restated Kyndryl 2021 Long-Term Performance Plan with 94% support. This amendment increases the number of common shares issuable under the plan by 7,600,000 shares.
- Election of Directors: Six director nominees were elected, each receiving approximately 90% of the votes cast. The nominees include John D. Harris II, Janina Kugel, Denis Machuel, Rahul N. Merchant, Jana Schreuder, and Howard I. Ungerleider.
- Executive Compensation: The advisory vote to approve the compensation of named executive officers passed with 75% of the votes present and entitled to vote.
- Independent Auditor: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2027, with 97% support.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The document serves as a disclosure of the completed shareholder vote and the ratification of the auditor.
Key Facts for Investor Verification
- Verify the specific terms of the 7,600,000 share increase in the Amended and Restated Kyndryl 2021 Long-Term Performance Plan (Exhibit 10.1).
- Review the 2026 Proxy Statement (filed June 16, 2026) for detailed descriptions of the director nominees and executive compensation rationale.
- Confirm the fiscal year end date of March 31, 2027, for the newly ratified audit period.